Detail of GM0037
Summary
The genetically modified enzybiotic, named LysK325-495 , constructed by Truncation strategy, decrease the lytic activity.With LysK325-495
Sequence Length: 167 AA.
Mass: 18161.7 Da.
Isoelectric Point: 10.13
Function: show faint activity in both the zymogram and turbidity reduction assays, but no detectable activity in either plate lysis or MIC assays
Construction
GM0037, constructed by Truncation strategy. No schema construted on GM0037
Details:
GM0037[1-171]: derive from protein I6X5A8 sequence 325-495
I6X5A8, 495 AA., the LysK from Staphylococcus phage Fi200W
Source: Staphylococcus phage Fi200W
196-369: IPR002502, the N-acetylmuramoyl-L-alanine amidase domain
409-481: IPR003646, the SH3-like domain, bacterial-type?
Linking to UniprotKB
Linging to InterPro
Domains and repeats
29-160: IPR007921, the CHAP domain196-369: IPR002502, the N-acetylmuramoyl-L-alanine amidase domain
409-481: IPR003646, the SH3-like domain, bacterial-type?
GO term prediction
Molecular Function: 0008745, the N-acetylmuramoyl-L-alanine amidase activityLinking to UniprotKB
Linging to InterPro
Annotation
1-171
84-150
: CBD, SH3b domain, derived from staphylococcal bacteriophage endolysin LysK;Domain and repeats:
85-157
: IPR003646,SH3-like domain, bacterial-type?; GO term prediction:
PTACPHRSMVLHTGFNPVTQGRPSQAIMNKLKDYFIKQIKNYMDKGTSSSTVVKDGKTSSASTPATRPVTGSWKKNQYGTWYKPENATFVNGNQPIVTRIGSPFLNAPVGGNLPAGATIVYDEVCIQAGHIWIGYNAYNGNRVYCPVRTCQGVPPNQIPGVAWGVFK